Primer: BioAge Labs (BIOA US) - Aug 2026
BioAge Labs is a clinical-stage biopharmaceutical company focused on developing therapeutics for metabolic diseases by targeting the biology of...
88 Views
Biopharma Week in Review - December 9, 2024
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, BIOA discontinued...
376 Views
BioAge Labs Launches IPO Roadshow, Seeks To Raise Up To $150M on the Nasdaq Exchange
GLP-1 biopharma company BioAge Labs will price its IPO in September. I have a positive view of initial public offering and expect a strong first...
548 Views
BioAge Labs IPO Preview: Investor Focus Has Turned To Azelaprag, A Huge Market Potential
California-based BioAge Labs files for an IPO and plans to raise capital for clinical trials of their lead compound, Azelaprag, in combination with...
459 Views
No more insights